Jul 25, 2011 | Laboratory News, Laboratory Pathology
Mayo Clinic to support one of China’s largest clinical laboratory companies
In a trans-Pacific Ocean collaboration with major implications, two important players in clinical laboratory and anatomic pathology testing in their respective countries have inked a multi-year pact. On June 27, 2011, Mayo Clinic of Rochester, Minnesota, announced its agreement with Wuhan Kindstar Globalgene Technology, Inc. (Kindstar), of Wuhan, Hubei Province, China.
In the press release it issued about the agreement, Mayo Clinic said that it would support Kindstar by providing “specialized laboratory support based on provision of knowledge from Mayo Clinic’s Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Medical Laboratories.” Mayo Clinic also said that it will receive equity in Kindstar and had participated in Kindstar’s Series B financing, which raised approximately U.S. $11 million.
(more…)
May 19, 2011 | Laboratory Pathology, News From Dark Daily
IVD manufacturers often introduce their newest technologies in Europe before the United States
DATELINE: BERLIN, GERMANY: With so many changes happening to clinical pathology laboratory testing in developed nations around the world, there is keen interest in evolving technologies, along with new medical laboratory instruments and automation products that clinical biochemists and pathologists will use, in the near future, to improve the quality of the clinical laboratory testing services they provide to physicians.
Here at the IFCC-WorldLab Berlin 2011 conference, pathologists and clinical chemists from the United States got an early peek at some of the latest and newest solutions developed by the world’s largest in vitro diagnostics (IVD) manufacturers. Many products on display at the IFCC WorldLab Exhibition have only been cleared for sale by the European Union. These products do not have clearance by the U.S. Food and Drug Administration (FDA) in the United States for sale and use in this country.
(more…)
Apr 18, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Interesting technology could be incorporated into medical laboratory tests
Though still in early development, “SmartPills” —a technology now being adapted for therapeutic drug delivery and monitoring—could be used in ways that bring pathologists into closer consultation with primary care physicians.
Using new drug-delivery technology created by California-based Proteus Biomedical, the SmartPill sends information from inside the patient’s body to a chip that’s worn outside on the skin in a patch, or embedded under the skin. The chip then uploads the data to a Smartphone or through the Internet to the prescribing physician.
(more…)
Mar 11, 2011 | Laboratory News, Laboratory Pathology
Agreement with Germany’s INSTAND will include developing clinical lab proficiency testing program in Egypt
DATELINE: CAIRO, EGYPT—Here in Egypt’s capital city, the Egyptian Society of Laboratory Medicine (ESLM) is conducting its 22nd Annual Conference. One of Wednesday’s main sessions during this gathering of pathologists and clinical laboratory scientists centered on the topic of ISO 15189, as well as Lean and Six Sigma methods.
Your Dark Daily Editor, Robert Michel, is here in Cairo and delivered two presentations during this session. One presentation addressed growing global acceptance of ISO 15189. The second presentation discussed the adoption and use of Lean and Six Sigma by medical laboratories throughout the world. There is keen interest in ISO 15189 among Egyptian pathologists because the nation is incorporating ISO 15189 into its national program for accreditation of clinical pathology laboratories. (more…)
Feb 8, 2011 | Laboratory News, Laboratory Pathology
Clinical pathology laboratory customers of Beckman Coulter shouldn’t see major changes
Yesterday came news that Danaher Corporation (NYSE: DHR) of Washington, D.C., would acquire Beckman Coulter, Inc., (NYSE: BEC) of Brea, California, in a transaction valued at $6.8 billion. Beckman is among the world’s larger manufacturers of in vitro diagnostics (IVD) analyzers and automation for clinical pathology laboratories.
For pathologists and medical laboratory administrators, the significance of the acquisition is that consolidation continues in the IVD testing industry. Beckman Coulter itself grew to substantial size through a series of acquisitions it completed over the past two decades. For 2009, Beckman Coulter reported revenue of $3.3 billion.
(more…)
